找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Chemo- and Immunopharmacology; 1. Chemopharmacology Georges Mathé,Franco M. Muggia Book 1980 Springer-Verlag Berlin Heidelberg 1980

[復(fù)制鏈接]
樓主: Jurisdiction
51#
發(fā)表于 2025-3-30 11:17:05 | 只看該作者
Vindesine: A New Vinca Alkaloid,xperimental neurotoxicity, and it inhibits the polymerization of tubulin. Its terminal half-life is 24 h and its plasma clearance is intermediate between those of vinblastine (VLB) and VCR. The maximal tolerated dose is 4–5 mg/m./week, the dose-limiting toxicity being myelosuppression (nadir by days
52#
發(fā)表于 2025-3-30 13:00:44 | 只看該作者
,The Epipodophyllotoxin Derivatives VM-26 and VP-16-213, 1976–1979, a Review,od, but the greatest lethal effect is experienced in the late S and G. phases. In transplanted tumors both drugs have shown marked schedule dependency and human studies also support this..As a single agent VP 16-213 is among the most active drugs in small-cell carcinoma of the lung. Significant clin
53#
發(fā)表于 2025-3-30 19:55:47 | 只看該作者
54#
發(fā)表于 2025-3-30 21:07:15 | 只看該作者
55#
發(fā)表于 2025-3-31 03:50:25 | 只看該作者
56#
發(fā)表于 2025-3-31 05:25:00 | 只看該作者
1,2-Diaminocyclohexane Platinum Derivatives of Potential Clinical Value,ycin, adriamycin, Cytoxan (cyclophosphamide), vindesine, or the arabinosylcytosine (ara-C) derivatives. With these combinations, many investigators have reported on activity in germ cell tumors of the testis, carcinoma of the head and neck, penis, cervix, bladder, lung, esophagus, and ovary [1,7]. I
57#
發(fā)表于 2025-3-31 12:17:03 | 只看該作者
58#
發(fā)表于 2025-3-31 15:29:41 | 只看該作者
Pers?nlichkeitsst?rung und Neurose associated with high-dose infusions, contribute to the chronic toxicity of MTX administration, and cross-react to a significant degree in radioimmunoassay methods for measurement of MTX concen- trations.
59#
發(fā)表于 2025-3-31 17:38:41 | 只看該作者
Pers?nlichkeitsst?rung und Neuroset increased by the high-dose methotrexate, although the antitumor activity of the combination appears enhanced. Attempts at further increasing the intensity of this regimen or comparative trials with other therapy appears warranted.
60#
發(fā)表于 2025-3-31 23:56:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 19:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
百色市| 茶陵县| 金门县| 独山县| 精河县| 黄浦区| 湘潭县| 宝坻区| 双城市| 贵州省| 多伦县| 和平县| 界首市| 宁强县| 清河县| 屏山县| 儋州市| 九台市| 惠州市| 馆陶县| 建水县| 东辽县| 寿宁县| 洮南市| 永德县| 定边县| 格尔木市| 太湖县| 屏南县| 横山县| 镇巴县| 读书| 桓仁| 治县。| 邢台市| 旬邑县| 安福县| 曲阜市| 彭山县| 连城县| 额济纳旗|